Learning objectives: Describe the clinical features of DADA2 and VEXASsyndrome.

Explain the difference between genotype-first approaches and phenotype-driven strategies for disease gene discovery.

Session date: 
Tuesday, December 8, 2020 - 12:00pm to 1:00pm
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Daniel L. Kastner, MD, PhD